
Journal of Cellular and Molecular Medicine, Journal Year: 2024, Volume and Issue: 28(8)
Published: April 1, 2024
The evolving landscape of personalized medicine necessitates a shift from traditional therapeutic interventions towards precision-driven approaches. Embracing this paradigm, our research probes the efficacy aqueous crude extract (ACE) Calocybe indica in cervical cancer treatment, merging botanical insights with advanced molecular research. We observed that ACE exerts significant influences on nuclear morphology and cell cycle modulation, further inducing early apoptosis showcasing prebiotic attributes. Characterization have identified several phytochemicals including presence octadeconoic acid. Simultaneously, utilizing Molecular Dynamics (MD) simulations, we deciphered intricate interactions between Vascular Endothelial Growth Factor (VEGF) Octadecanoic acid to establish C.indica's role as an anticancer agent. Our study delineates acid's potential robust binding partner for VEGF, comprehensive analyses RMSD RMSF profiles highlighting stability adaptability protein-ligand interactions. Further in-depth thermodynamic explorations via MM-GBSA calculations reveal VEGF-Octadecanoic complex. Emerging innovations, encompassing proteolysis-targeting chimeras (PROTACs) avant-garde nanocarriers, are discussed context their synergy compounds like P&C. This convergence underscores profound awaiting clinical exploration. offers holistic perspective promising avenues facilitated by C. against cancer, intricately woven prospective integration precision therapeutics modern oncology.
Language: Английский